[144] Innovative Eyewear, Inc. Series A Warrants 8/16/27 SEC Filing

Rhea-AI Filing Summary

Innovative Eyewear, Inc. (LUCYW) Form 144 reports a proposed sale of 3,009 common shares to be executed through Raymond James & Associates on 08/19/2025 on NASDAQ. The filing lists an aggregate market value of $5,894.17 for the shares and states total shares outstanding of 4,574,602, providing the basic size and timing of the planned transaction.

The securities were acquired as an RSU grant on 08/19/2025 (noted amount: 9,600 shares) with cash listed as the payment type. The filer attests by signature that they do not possess undisclosed material adverse information about the issuer.

Positive

• Clear disclosure of broker, number of shares, aggregate market value, and exchange (NASDAQ)
• Acquisition details provided (RSU grant and date) which support transparency around the provenance of the shares
• Filer attestation that they do not possess undisclosed material adverse information

Negative

• None.

Insights

Securities Compliance Analyst

TL;DR: Routine Form 144 filing disclosing an intended sale of restricted stock via a broker with required attestation.

The filing presents the standard disclosures required under Rule 144: identity of broker, number of shares proposed for sale, market value, and outstanding shares. It also documents the acquisition as an RSU grant and includes the attestation that no material nonpublic information is known to the seller. From a compliance perspective, the form contains the necessary elements to support an issuer-affiliated sale under Rule 144 procedures.

Equity Research Analyst

TL;DR: Small, routine insider sale disclosed; limited investor impact based on disclosed size and value.

The transaction size—3,009 shares worth $5,894.17—represents a very small portion of the stated outstanding share count (4,574,602). The acquisition origin is an RSU grant dated the same day, and the sale will route through a listed broker on NASDAQ. Based solely on the filing's figures, this appears operationally routine and not material to equity valuation.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	3009	5894.17	4574602	08/19/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/19/2025	RSU Grant	Issuer			9600	08/19/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the LUCYW Form 144 disclose about the proposed sale?

It discloses a proposed sale of 3,009 common shares on 08/19/2025 via Raymond James on NASDAQ, with an aggregate market value of $5,894.17.

How many shares outstanding does the filing list for LUCYW?

The filing lists 4,574,602 shares outstanding.

How were the securities acquired according to the filing?

The securities were acquired as an RSU grant on 08/19/2025, showing 9,600 shares acquired and cash as the payment type.

Through which broker will the LUCYW shares be sold?

The sale is to be executed through Raymond James & Associates at their St. Petersburg, FL address.

Does the filer state they possess undisclosed material information?

No; by signing the form the filer represents they do not know any material adverse information